Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

Abstract

1-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) causes degeneration of the dopaminergic nigrostriatal pathway in several animal species, including humans1,2, monkeys3,4 and mice5–7. Changes observed after MPTP administration include marked decrements in the neostriatal content of dopamine and its major metabolites, dihydroxyphenylacetic acid and homovanillic acid, and a greatly diminished capacity of neostriatal synaptosomes to take up 3H-dopamine5,6. In contrast, there is no pronounced loss of serotonin in the neostriatum or of dopamine and its metabolites in other brain areas in MPTP-treated animals. The oxidative metabolism of MPTP to 1-methyl-4-phenyl pyridine, a positively charged species, has been suggested as a critical feature in the neurotoxic process8. Moreover, in rat brain preparations, the monoamine oxidase (MAO) inhibitor pargyline and the specific MAO-B inhibitor deprenil can prevent the formation of 1-methyl-4-phenyl-pyridine from MPTP, while the specific MAO-A inhibitor clorgyline has no such effect9, suggesting that MAO, and specifically MAO-B, is responsible for the oxidative metabolism of MPTP. We now report that pargyline, nialamide and tranylcypromine, which inhibit both MAO-A and MAO-B, when administered to mice before MPTP, protect against MPTP-induced dopaminergic neurotoxicity. Deprenil is also protective, but clorgyline is not. Our data are consistent with the premise that MAO-B has a crucial role in MPTP-induced degeneration of the nigrostriatal dopaminergic neuronal pathway.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Davis, G. C. et al. Psychol. Res. 1, 249–254 (1979).

    ADS  CAS  Google Scholar 

  2. Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I. Science 219, 979–980 (1983).

    Article  ADS  CAS  Google Scholar 

  3. Burns, R. S. et al. Proc. natn. Acad. Sci. U.S.A. 80, 4546–4550 (1983).

    Article  ADS  CAS  Google Scholar 

  4. Langston, J. W., Forno, L. S., Rebert, C. S. & Irwin, I. Brain Res. 292, 390–394 (1984).

    Article  CAS  Google Scholar 

  5. Heikkila, R. E., Cabbat, F. S., Manzino, L. & Duvoisin, R. C. Fedn Proc. 43, 743 (1984).

    Google Scholar 

  6. Heikkila, R. E., Hess, A. & Duvoisin, R. C. Science 224, 1451 (1984).

    Article  ADS  CAS  Google Scholar 

  7. Hallman, H., Olson, L. & Jonsson, G. Eur. J. Pharmac. 97, 133–136 (1984).

    Article  CAS  Google Scholar 

  8. Markey, S. P., Johannessen, J. N., Chiueh, C. C., Burns, R. S. & Herkenham, M. A. American College of Neuropsychopharmacology Meeting, Abstr., 69 (1983).

  9. Chiba, K., Trevor, A. & Castagnoli, N. Biochem. biophys. Res. Commun. 120, 574–578 (1984).

    Article  CAS  Google Scholar 

  10. Neff, N. H. & Goridis, C. Adv. Biochem. Psychopharmac. 5, 307–323 (1972).

    CAS  Google Scholar 

  11. Mayer, G. S. & Shoup, R. E. J. Chromatogr. 255, 533–544 (1983).

    Article  CAS  Google Scholar 

  12. Gershanik, O., Heikkila, R. E. & Duvoisin, R. C. Brain Res. 261, 358–360 (1983).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heikkila, R., Manzino, L., Cabbat, F. et al. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311, 467–469 (1984). https://doi.org/10.1038/311467a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/311467a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing